Obinutuzumab, solution for IV infusion, 1000 mg/40 mL, Gazyva®, Roche Products Pty Ltd Public Summary Document (PSD) July 2014 PBAC Meeting - (PDF 212 KB) Public Summary Document (PSD) July 2014 PBAC Meeting - (Word 217 KB)